美国的一个早期类风湿性关节炎治疗评估登记处（ERATER）。

An Early Rheumatoid Arthritis Treatment Evaluation Registry (ERATER) in the United States.

作者信息

Sokka T, Pincus T

机构信息

Vanderbilt University Medical Center, Vanderbilt University School of Medicine, 203 Oxford House, Box 5, Nashville, TN 37232-4500, USA.

出版信息

Clin Exp Rheumatol. 2005 Sep-Oct;23(5 Suppl 39):S178-81.

PMID:16273804

Abstract

An Early Rheumatoid Arthritis Treatment Evaluation Registry (ERATER) was established in 2001 to enroll patients with a disease duration of 3 years or less, in order to analyze treatment patterns in an era of biological therapies and to study the long-term outcomes of rheumatoid arthritis (RA). Patients were assessed at baseline according to a standard protocol to evaluate their rheumatoid arthritis (SPERA). Similar data from earlier cohorts with RA in the same community will allow for comparisons with treatments and outcomes from previous decades. This essay describes the background regarding the identification of the cohort, methods for data collection, and observations to date.

摘要

2001年建立了早期类风湿性关节炎治疗评估登记处（ERATER），以招募病程在3年及以内的患者，目的是分析生物疗法时代的治疗模式，并研究类风湿性关节炎（RA）的长期预后。根据标准方案在基线时对患者进行评估，以评价其类风湿性关节炎（SPERA）。来自同一社区早期类风湿性关节炎队列的类似数据将有助于与过去几十年的治疗方法和预后进行比较。本文描述了该队列识别的背景、数据收集方法以及迄今为止的观察结果。